By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Chesapeake Energy Corporation
Stock ticker CHK
Live stock price [stckqut]CHK[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=chk

 

Chesapeake Energy Corporation (Chesapeake) is a natural gas and oil exploration and production company. Chesapeake is engaged in the exploration, development and acquisition of properties for the production of natural gas and oil from underground reservoirs. It also provides substantial marketing, midstream, drilling and other oilfield services. Its operations are located onshore and in the continental United States. As of December 31, 2011, the Company owned interests in approximately 45,700 producing natural gas and oil wells that produced approximately 3.5 billion cubic feet of natural gas equivalent per day, net to its interest. It operates in three segments: exploration and production; marketing, gathering and compression, and oilfield services. In March 2011, it sold all of its Fayetteville Shale assets. In July 2012, it sold its interest in Chesapeake Midstream Partners, L.P. to Global Infrastructure Partners. In October 2012, it sold asset packages in the Permian Basin.
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Weight Watchers International, Inc.
Stock ticker WTW
Live stock price [stckqut]WTW[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Poor
EPS growth Fair
P/E growth Poor
EBIT growth Fair

ANALYSIS

Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $44.65
Target stock price (averages with growth) $57.48
Target stock price (averages with no growth) $54.56
Target stock price (manual assumptions) $99.91

The following company description is from Google Finance: http://www.google.com/finance?q=wtw
Weight Watchers International, Inc. (WWI) is a global-branded consumer company and a provider of weight management services, operating globally through a network of Company-owned and franchise operations. Through WeightWatchers.com, the Company offers Internet subscription weight management products to consumers and maintains an interactive presence on the Internet for the Weight Watchers brand. As of December 31, 2011, it provided two Internet subscription offerings: Weight Watchers Online and Weight Watchers eTools. Weight Watchers Online provides interactive and personalized resources that allow users to follow its weight management plans via the Internet. WWI offers its two Internet subscription products in eleven countries, including the United States, the United Kingdom, Germany and Australia. In April 27, 2011, WWI acquired the 49% minority equity interest in a joint venture with Groupe DANONE S.A.

 

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Automatic Data Processing
Stock ticker ADP
Live stock price [stckqut]ADP[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Poor
EPS growth Fair
P/E growth Poor
EBIT growth Poor

ANALYSIS

Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $49.64
Target stock price (averages with growth) $58.08
Target stock price (averages with no growth) $50.99
Target stock price (manual assumptions) $67.89

The following company description is from Google Finance: http://www.google.com/finance?q=adp
Automatic Data Processing, Inc. (ADP), is a provider of business outsourcing solutions. ADP offers a wide range of human resource, payroll, tax and benefits administration solutions from a single source. ADP is also a provider of integrated computing solutions to auto, truck, motorcycle, marine, recreational vehicle, and heavy equipment dealers throughout the world. The Company’s operating segments include: Employer Services, Professional Employer organization (PEO) Services, and Dealer Services. In October 2011, the Company acquired WALLACE – The Training Tax Credit Company. In January 2012, the Company acquired Indian payroll business of Randstad Holding NV. In April 2012, it acquired the human resource solutions subsidiary of SHPS, Inc.

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Pfizer Inc.
Stock ticker PFE
Live stock price [stckqut]PFE[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $30.5
Target stock price (averages with growth) $30.14
Target stock price (averages with no growth) $24.31
Target stock price (manual assumptions) $30.09

The following company description is from Google Finance: http://www.google.com/finance?q=pfe
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. On August 1, 2011, it completed the sale of its Capsugel business. In October 2011, it acquired Icagen, Inc. In December 2011, it acquired the consumer healthcare business of Ferrosan Holding A/S. In December 2011, it acquired Excaliard Pharmaceuticals, Inc. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc.

 

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

 

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Merck & Co., Inc.
Stock ticker MRK
Live stock price [stckqut]MRK[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $67.23
Target stock price (averages with growth) $80.66
Target stock price (averages with no growth) $70.94
Target stock price (manual assumptions) $64.58

The following company description is from Google Finance: http://www.google.com/finance?q=mrk
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. In May 2011, it acquired Inspire Pharmaceuticals, Inc. In September 2011, the Company sold its 50% interest in the Johnson & Johnson-Merck Consumer Pharmaceuticals Company joint venture. In December 2011, the Company established an Asia Research & Development (R&D) headquarters for drug discovery and development located in Beijing, China.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.